Voxtalisib

DB12400InvestigationalSmall molecule

Voxtalisib has been used in trials studying the treatment of Cancer, Melanoma, Lymphoma, Glioblastoma, and Breast Cancer, among others.

Mechanism: Pharmacologically active on Serine/threonine-protein kinase mTOR
Curator reviewed
Formula / weight: C₁₃H₁₄N₆O · 270.296 g/mol (avg)
Code names: SAR-245409

Resolves to

Compound

Structure

InChIKeyRGHYDLZMTYDBDT-UHFFFAOYSA-NSMILESCCN1C(=O)C(=CC2=C(C)N=C(N)N=C12)C1=CC=NN1

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

10Clinical trialsPhase, status and sponsor resolved per trial

9+ReferencesStructured and connected to the statements they support

Which drugs share a target with Voxtalisib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.